Myeloma Trial Aims to Use Genetic Profile for Treatment Optimization
To improve options for patients with refractory disease, researchers seek to bolster data behind genetic profiling as a way to guide the selection of treatment.
To improve options for patients with refractory disease, researchers seek to bolster data behind genetic profiling as a way to guide the selection of treatment.
Almac Diagnostics has published analytical validation of a 70-gene assay designed for use with formalin-fixed paraffin-embedded samples.
Europe halts sales of textured breast implants as more studies demonstrate a link between this type of implant and the development of a rare lymphoma.
A new screening approach identifies more than 200 lncRNAs essential for survival in CML cells, suggesting lncRNAs could be good prospective targets for therapies.
The model was developed using machine learning techniques and programmed with data from a Danish cancer registry.